ASX reports blitz: CSL, SEK, VCX, RBL, CGF, BHP & CAR
Drew Meredith, CFP and Owen Rask are back on The Australian Investors Podcast for ASX reporting season, covering CSL Limited (ASX:CSL), BHP Group Ltd (ASX:BHP) and more.
Looking for growth in 2020 and beyond? Here are the latest ASX growth stock ideas, stories and news from our team at Rask Media. We think it’s fair to say that Australia’s ASX growth stocks are some of the best in the world, given their potential for international growth and the fact that many Australian companies also offer their dividends with franking credits.
Drew Meredith, CFP and Owen Rask are back on The Australian Investors Podcast for ASX reporting season, covering CSL Limited (ASX:CSL), BHP Group Ltd (ASX:BHP) and more.
The Cochlear Limited (ASX:COH) share price is under the spotlight as the hearing device business announced its FY22 result.
I think that reporting reason can be a catalyst to go hunting for ASX shares. August is a good month to go looking for opportunities.
The Pro Medicus Ltd (ASX:PME) share price is down after the company reported strong growth in FY22 and a good outlook for FY23.
Nick Griffin is the Chief Investment Officer of Munro Partners, one of Australia’s largest and fastest-growing global equities fund managers. Nick Griffin recently sat down with me, Owen Rask, on The Australian Investors Podcast to talk about life, money and investing.
The Redbubble Ltd (ASX:RBL) share price has plunged 37% after the company released its FY22 result, which showed a loss.
The CSL Limited (ASX:CSL) share price is in focus after the ASX healthcare share reported its FY22 result.
The SEEK Limited (ASX:SEK) share price fell 5% today after the job ad business released its FY22 report. FY23 indicators are looking weaker.
The Temple & Webster Group Ltd (ASX:TPW) share price has soared around 20% after revealing its FY22 report.
Drew Meredith, CFP and Owen Rask are back on The Australian Investors Podcast for ASX reporting season, covering CSL Limited (ASX:CSL), BHP Group Ltd (ASX:BHP) and more.
The Cochlear Limited (ASX:COH) share price is under the spotlight as the hearing device business announced its FY22 result.
I think that reporting reason can be a catalyst to go hunting for ASX shares. August is a good month to go looking for opportunities.
The Pro Medicus Ltd (ASX:PME) share price is down after the company reported strong growth in FY22 and a good outlook for FY23.
Nick Griffin is the Chief Investment Officer of Munro Partners, one of Australia’s largest and fastest-growing global equities fund managers. Nick Griffin recently sat down with me, Owen Rask, on The Australian Investors Podcast to talk about life, money and investing.
The Redbubble Ltd (ASX:RBL) share price has plunged 37% after the company released its FY22 result, which showed a loss.
The CSL Limited (ASX:CSL) share price is in focus after the ASX healthcare share reported its FY22 result.
The SEEK Limited (ASX:SEK) share price fell 5% today after the job ad business released its FY22 report. FY23 indicators are looking weaker.
The Temple & Webster Group Ltd (ASX:TPW) share price has soared around 20% after revealing its FY22 report.
Want to level-up your analytical skills and investing insights but don’t know where to start? We can help. Join 40,000+ Australian investors on our mailing list today and we’ll send you our favourite podcasts, courses, resources, investment articles and podcasts every week. Delivered to your inbox every Sunday morning. Grab a coffee and let Owen and the team bring you the best investment insights every week.
The information on this website is general financial advice only. That means, the advice does not take into account your objectives, financial situation or needs. Because of that, you should consider if the advice is appropriate to you and your needs, before acting on the information. In addition, you should obtain and read the product disclosure statement (PDS) and Target Market Determination before making a decision to acquire any financial product. If you don’t know what your needs are, you should consult a trusted and licensed financial adviser who can provide you with personal financial product advice. Please read our Terms & Conditions and Financial Services Guide before using this website.
“Rask Invest” is considered a financial product and has a Product Disclosure Statement (PDS) and Target Market Determination (TMD), issued by InvestSMART. These documents can be accessed on the Rask Invest website. Please seek professional advice before making any investment decision with respect to Rask Invest.
© Rask Australia 2024